Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radhakrishnan P Iyer

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2012
Metabolism, pharmacokinetics, tissue distribution, and stability studies of the prodrug analog of an anti-hepatitis B virus dinucleoside phosphorothioateJohn E Coughlin, Rajendra K Pandey, Seetharamaiyer Padmanabhan, et al.
Journal of Medical Virology|March 18, 2017
SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variantsMeleri Jones, Morven E Cunningham, Peter Wing, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2010
Orally bioavailable anti-HBV dinucleotide acyloxyalkyl prodrugsJohn E Coughlin, Seetharamaiyer Padmanabhan, Guangrong Zhang, et al.
Frontiers in Immunology|December 28, 2020
NOD2/RIG-I Activating <i>Inarigivir</i> Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in MiceArshad Khan, Vipul K Singh, Abhishek Mishra, et al.
Plos One|January 6, 2017
Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in WoodchucksManasa Suresh, Kyle E Korolowicz, Maria Balarezo, et al.
Plos One|August 24, 2016
Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis BKyle E Korolowicz, Radhakrishnan P Iyer, Stefanie Czerwinski, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2022
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis BMan-Fung Yuen, Chi-Yi Chen, Chun-Jen Liu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2012
Metabolism, pharmacokinetics, tissue distribution, and stability studies of the prodrug analog of an anti-hepatitis B virus dinucleoside phosphorothioateJohn E Coughlin, Rajendra K Pandey, Seetharamaiyer Padmanabhan, et al.
Journal of Medical Virology|March 18, 2017
SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variantsMeleri Jones, Morven E Cunningham, Peter Wing, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2010
Orally bioavailable anti-HBV dinucleotide acyloxyalkyl prodrugsJohn E Coughlin, Seetharamaiyer Padmanabhan, Guangrong Zhang, et al.
Frontiers in Immunology|December 28, 2020
NOD2/RIG-I Activating <i>Inarigivir</i> Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in MiceArshad Khan, Vipul K Singh, Abhishek Mishra, et al.
Plos One|January 6, 2017
Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in WoodchucksManasa Suresh, Kyle E Korolowicz, Maria Balarezo, et al.
Plos One|August 24, 2016
Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis BKyle E Korolowicz, Radhakrishnan P Iyer, Stefanie Czerwinski, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2022
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis BMan-Fung Yuen, Chi-Yi Chen, Chun-Jen Liu, et al.
Pageof 2